Inhibition of αIIbβ3 Ligand Binding by an αIIb Peptide that Clasps the Hybrid Domain to the βI Domain of β3

PloS One
Wen Hwa LeeChristilla Bachelot-Loza

Abstract

Agonist-stimulated platelet activation triggers conformational changes of integrin αIIbβ3, allowing fibrinogen binding and platelet aggregation. We have previously shown that an octapeptide, p1YMESRADR8, corresponding to amino acids 313-320 of the β-ribbon extending from the β-propeller domain of αIIb, acts as a potent inhibitor of platelet aggregation. Here we have performed in silico modelling analysis of the interaction of this peptide with αIIbβ3 in its bent and closed (not swing-out) conformation and show that the peptide is able to act as a substitute for the β-ribbon by forming a clasp restraining the β3 hybrid and βI domains in a closed conformation. The involvement of species-specific residues of the β3 hybrid domain (E356 and K384) and the β1 domain (E297) as well as an intrapeptide bond (pE315-pR317) were confirmed as important for this interaction by mutagenesis studies of αIIbβ3 expressed in CHO cells and native or substituted peptide inhibitory studies on platelet functions. Furthermore, NMR data corroborate the above results. Our findings provide insight into the important functional role of the αIIb β-ribbon in preventing integrin αIIbβ3 head piece opening, and highlight a potential new therapeutic approach to p...Continue Reading

References

Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J C LoftusM H Ginsberg
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I F CharoD R Phillips
Mar 16, 2002·Nature Structural Biology·Natalia BeglovaTimothy A Springer
Oct 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Brian D Adair, Mark Yeager
Jan 18, 2006·Journal of Thrombosis and Haemostasis : JTH·P LegendreD Baruch
Jan 5, 2007·Annual Review of Immunology·Bing-Hao LuoTimothy A Springer
Apr 18, 2008·The Journal of Biological Chemistry·Tong-Lay LauTobias S Ulmer
Jul 23, 2008·Journal of Peptide Science : an Official Publication of the European Peptide Society·Ruxandra Maria StanicaVasilios Tsikaris
Mar 24, 2010·Nature Reviews. Molecular Cell Biology·Sanford J ShattilMark H Ginsberg
Oct 5, 2010·The Journal of Biological Chemistry·Tetsuji KamataSadakazu Aiso
Mar 1, 2012·Thrombosis and Haemostasis·Paul C Armstrong, Karlheinz Peter
Apr 13, 2013·Circulation Research·Kamila BledzkaEdward F Plow
Jun 27, 2013·The Journal of Cell Biology·Jieqing ZhuTimothy A Springer

❮ Previous
Next ❯

Methods Mentioned

BETA
electron microscopy
flow cytometry
Transfection
transfections
NMR

Software Mentioned

GraphPad
Prism
Pro
ICM
Histolab
Archimed

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.